H ypoxia-induced angiogenesis increases blood flow and oxygen delivery to ischemic tissues and may contribute to recovery after stroke. 1 Angiogenesis occurs in human brain after stroke, with endothelial cell proliferation after 3 to 4 days, a dense capillary network by 1 week, and neovascular infiltration by 2 to 4 weeks. 2 Within 3 months, microvessel density in the infarct area increases relative to the contralateral side, and extracts of infarcted brain tissue induce angiogenesis in chick chorioallantoic membranes. 3 These alterations may help to restore cerebral blood flow in stroke survivors 4 and protect against recurrent ischemia. Therefore, investigating mechanisms of angiogenesis after cerebral hypoxia or ischemia may provide new insights into stroke pathophysiology and treatment.
Endoglin (CD105) is a homodimeric membrane protein that binds transforming growth factor (TGF)-␤1 and -␤3. 5 Loss-of-function mutations in the human gene ENG cause hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease), 6 which produces capillary and venous telangiectases affecting the skin, mucous membranes, and respiratory, gastrointestinal, and urinary tracts. 7 Endoglin is upregulated in tumor vasculature, and the density of endoglinimmunopositive microvessels correlates inversely with cancer survival. 8, 9 Endoglin is also overexpressed in endothelial cells of healing wounds, embryos, psoriatic skin, and rheumatoid synovia, 10 -12 suggesting that it is an endothelial proliferation marker. Vascular smooth muscle development and endothelial remodeling are defective in endoglinknockout mice. 7 Hypoxic regulation of gene expression involves extracellular signal-related kinase (ERK), which is widely associated with cell survival, and p38 mitogen-activated protein kinase (MAPK) and Jun amino-terminal kinase (JNK), which are implicated in cell death. 13, 14 However, little is known regarding expression of endoglin in cerebral endothelial cells under hypoxic or ischemic conditions. To investigate how hypoxia and ischemia regulate endoglin expression in cerebral microvascular endothelial cells and to determine which signaling pathways are involved, we examined expression of endoglin mRNA and protein in hypoxic bEND.3 mouse brain capillary endothelial cells and in focal cerebral ischemia in mice. bEND.3 cells exhibit endothelial properties, including expression of von Willebrand factor (vWF), 15 vascular endothelial growth factor receptors, 15 E-selectin, 16 platelet-endo-thelial cell adhesion molecule-1, 17 vascular cell adhesion molecule-1, 18 mucosal vascular addressin cell adhesion molecule-1, 18 endothelial NO synthase, 19 and endomucin. 20 bEND.3 cells can internalize acetylated low-density lipoprotein and produce capillary-like tubes in 3-dimensional cultures. 15 They form gap junctions and respond to mechanical injury with increased expression of connexin 43. 21 Our results show that hypoxia and ischemia induce expression of endoglin at both the mRNA and protein levels and that induction is regulated by the p38 pathway.
Materials and Methods

Reagents
MAPK kinase (MEK) inhibitor PD98059, p38 inhibitors SB202190 and SB203580, and SB202474 were from Calbiochem, JNK inhibitor dicumarol was from Sigma, and media and sera were from Cellgro.
Cell Culture
bEND.3, a polyoma middle T-transformed mouse brain capillary endothelial cell line, was maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum. 17, 22 TS11, a cell line derived from bEND.3 cells transfected with human thrombospondin-1, was produced as previously described 17, 22 and was cultured in Dulbecco's modified Eagle's medium containing hygromycin B (50 g/mL, GIBCO-BRL).
Hypoxia
Hypoxic cultures were maintained in modular incubator chambers (Billups-Rothenberg) for 0 to 24 hours at 37°C in humidified 95% N 2 /5% CO 2 , 13 and normoxic cultures were maintained in 95% air/5% CO 2 . PO 2 in culture medium was 156Ϯ5 mm Hg in normoxic cultures and 63Ϯ3 mm Hg in hypoxic cultures at 24 hours (nϭ3). Inhibitors were added 1 hour before hypoxia. Endothelial cell dysfunction or death was measured with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT). 13 Real-Time Polymerase Chain Reaction mRNA was extracted, reverse transcribed, and quantified by realtime polymerase chain reaction (PCR) as described. 23, 24 Endoglinspecific primers were 5Ј-CTGCCAATGCTGTGCGTGAA-3Ј (forward) and 5Ј-GCTGGAGTCGTAGGCCAAGT-3Ј (reverse); mouse ␤-actin-specific primers 5Ј-ACCGAGCGTGGCTACAGCTT-3Ј (forward) and 5Ј-TCAGGCAGCTCATAGCTCTT-3Ј (reverse) were used as controls. The thermal profile was 50°C for 2 minutes and 95°C for 10 minutes, followed by 40 cycles of 95°C for 10 seconds and 60°C for 1 minute. In each plate, a dilution series of cDNA samples from untreated bEND.3 cells was run along with unknown samples. Data were analyzed with the use of ABI PRISM 7000 Sequence Detection System 1.0. All reactions were repeated at least 3 times to ensure reproducibility. Levels relative to normoxic reference samples were reported after normalization to ␤-actin, which was not altered by treatment.
Western Blotting
Fifty-microgram protein samples were loaded on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels and blotted onto polyvinylidene fluoride (PVDF) membranes (Bio-Rad), which were probed with primary antibody at 4°C overnight and secondary antibody at room temperature for 1 hour; signals were detected by chemiluminescence. Primary antibodies were rabbit anti-p38 (Santa Cruz); rat monoclonal anti-mouse endoglin (Cymbus Biotechnology Ltd); rabbit polyclonal anti-ERK1/2 (Promega); mouse monoclonal anti-␤-actin (Sigma); and rabbit polyclonal anti-phospho(Ser 15)-p53, polyclonal anti-phospho(Thr202/ Tyr204)-MAPK (ERK1/2), anti-phospho(Thr180/Tyr182)-p38 MAPK, and anti-phospho-JNK (Cell Signaling Technology, Inc). 
Plasmids and Transfection
Focal Cerebral Ischemia
Ischemia was induced in adult male Charles River CD1 mice by intraluminal middle cerebral artery occlusion (MCAO) with a suture, 27, 28 in accordance with institutional and National Institutes of Health guidelines. Physiological measurements, including arterial blood gas measurements and temperature, were performed, and the ischemic penumbra was identified by laser-Doppler flowmetry, as described. 28 The suture was left in place for 90 minutes and then withdrawn to allow reperfusion, and mice were killed 28 days later.
Immunohistochemistry
Frozen sections were fixed with methanol at Ϫ20°C for 10 minutes, incubated overnight at 4°C with rat monoclonal anti-mouse endoglin (Cymbus Biotechnology Ltd; 1:10), visualized with the use of Vectastain ABC kits (Vector Laboratories Inc) with diaminobenzidine as substrate, and counterstained with hematoxylin. For doublelabel immunocytochemistry, sections were fixed with 4% paraformaldehyde in PBS for 1 hour at room temperature, washed twice with PBS, and incubated in blocking solution with primary antibodies at 4°C overnight and with secondary antibodies at room temperature for 2 hours. Primary antibodies were the aforementioned endoglin antibody and rabbit polyclonal anti-vWF (Sigma; 1:500); secondary antibodies were rhodamine-conjugated goat anti-rat IgG 
Statistical Analysis
Experiments were repeated at least 3 times. Quantitative results were expressed as meanϮSEM. ANOVA and t tests were used for statistical analysis, with PϽ0.05 considered significant.
Results
bEND.3 cells proliferate rapidly in culture. Expression of thrombospondin-1 in bEND.3, producing cells designated TS11, reduces growth rate, saturation density, fibrinolytic activity, and ability to form hemangiomas and increases cord formation. 17, 22 TS11 cells expressed lower levels of endoglin mRNA and protein than bEND.3 cells transfected with control vector (Figure 1) , consistent with proliferationassociated induction of endoglin.
Endoglin expression after focal ischemia was examined in brain sections up to 28 days after MCAO with reperfusion. Endoglin immunoreactivity increased in the ischemic core compared with the same brain area on the contralateral side and was associated with vascular endothelial cells, as evidenced by colocalization with vWF expression (Figure 2) .
To determine the effect of hypoxia on endoglin expression, bEND.3 cells were exposed to hypoxia for 0 to 24 hours. Upregulation of endoglin mRNA (30% increase) was observed 4 hours after hypoxia and reached highest levels (90% increase) at 24 hours ( Figure 3A) ; endoglin protein expression also increased ( Figure 3B and 3C) .
To investigate mechanisms of endoglin upregulation, we used antibodies against phosphoactivated ERK, p38, and A, Cells were exposed to hypoxia for 0 to 24 hours, and total RNA was extracted and reverse transcribed. cDNA was used in real-time PCR to examine expression of endoglin relative to ␤-actin. Values (meanϮSEM; nϭ3) are expressed relative to reference (0 hours) samples and normalized to ␤-actin (*PϽ0.05, **PϽ0.01 vs 0 hours). B, Cells were exposed to normoxia (C) or hypoxia (H) for 8 or 24 hours, and 50-g protein samples from whole cell extracts were transferred to PVDF membranes for Western analysis of endoglin expression. Blots were stripped and reprobed with anti-␤-actin. C, Endoglin protein expression was quantified by computer densitometry, normalized to ␤-actin, and expressed as percent control expression at 0 hours (meanϮSE; nϭ3; *PϽ0.01 vs normoxic control).
JNK. Western blots showed phosphoactivation of ERK1/2 and p38, and to some extent JNK, after 16 to 24 hours of hypoxia ( Figure 4A and 4B). Total ERK1/2 (not shown) and p38 were unchanged. Thus, hypoxia appears to activate 3 major MAPK systems in bEND.3 cells.
Next we assessed the effects of MEK inhibitor PD98059 (20 mol/L), p38 inhibitor SB203580 or SB202190 or the inactive analogue SB202474 (all 5 mol/L), or JNK inhibitor dicumarol (100 mol/L), added 1 hour before hypoxia, on hypoxic induction of endoglin in bEND.3. Both p38 inhibitors and dicumarol reduced endoglin mRNA levels in hypoxic cultures, whereas PD98059 and SB202474 did not ( Figure 5A ). Levels of endoglin protein in hypoxic cultures were also decreased by p38 or JNK, but not MEK, inhibitors ( Figure 5B ). Dicumarol also reduced MTT absorbance (Figure 5C ), consistent with impaired metabolic function or reduced cell viability, and therefore no conclusion regarding the role of JNK in endoglin induction could be made. Thus, p38 but not MEK/ERK helps to mediate the effect of hypoxia on endoglin expression in bEND.3 cells.
Finally, we transfected bEND.3 cells with expression constructs encoding constitutively active or dominant negative MKK3, which specifically phosphorylates and activates p38 25 or constitutively active JNK1, and measured levels of endoglin mRNA 48 hours later. In normoxic cultures, endoglin mRNA expression was increased by approximately 45% by constitutively active MKK3(Glu) and by approximately 40% by constitutively active JNK1 and was reduced by approximately 40% by dominant negative MKK3(Ala) (Figure 6 ). In hypoxic cultures, dominant negative MKK3(Ala) markedly reduced hypoxic upregulation of endoglin mRNA, while constitutively active MKK3(Glu) or JNK1 enhanced the effect of hypoxia ( Figure 6 ). These results suggest that activation of p38, and perhaps JNK1, is involved in hypoxic induction of endoglin expression in bEND.3 cells. Hypoxia increases ERK, p38, and JNK phosphoactivation in bEND.3 cells. A, Cells were exposed to hypoxia for 0 to 24 hours, and 50-g protein samples from whole cell extracts were transferred to PVDF membranes for Western analysis of phosphoprotein expression, with total p38 as a control. B, Phosphoprotein expression was quantified by computer densitometry, normalized to ␤-actin, and expressed as percent control expression at 0 hours (meanϮSE; nϭ3). Figure 5 . Effects of protein kinase inhibitors on hypoxia-induced endoglin mRNA and protein expression in bEND.3 cells. Cells were treated for 1 hour with the MEK inhibitor PD98059 (PD), the p38 inhibitor SB203580 (SB1), the inactive analogue SB202474 (SB2), or the JNK inhibitor dicumarol (Di) and then exposed to hypoxia (H) for 16 hours. A, Total RNA was extracted and reverse transcribed, and cDNA was used in realtime PCR to examine endoglin mRNA expression relative to ␤-actin. Values (meanϮSEM; nϭ3) are expressed relative to reference (0 hours) samples and normalized to ␤-actin (*PϽ0.05, **PϽ0.01 vs normoxic control at left). B, Protein samples from whole cell extracts were loaded on 10% SDS-PAGE gels and transferred to PVDF membranes for Western analysis of endoglin expression. Blots were stripped and reprobed with anti-␤-actin. C indicates control. C, MTT absorbance, which reflects mitochondrial function and is reduced when mitochondrial function is impaired or cell viability is reduced, was expressed as a percentage of control absorbance in normoxic cultures (meanϮSE; nϭ3; *PϽ0.05 vs normoxic control at left).
Discussion
Angiogenesis is a well-documented consequence of focal cerebral ischemia. We found that endoglin expression correlates with endothelial cell proliferation and that hypoxia and ischemia upregulate endoglin expression, and we identified some of the signaling pathways involved. Hypoxic upregulation of endoglin expression may be mediated through p38 MAPK and JNK since hypoxic upregulation of endoglin was reduced by p38 inhibitors and by a dominant negative form of the p38-activating kinase MKK3 and was increased by constitutively active forms of MKK3 and JNK1.
bEND.3 cells are mouse brain endothelial cells transformed by polyoma middle T oncogenes. 29 As noted above, they exhibit numerous properties of untransformed endothelial cells. 15 Like other cell lines, they have advantages and disadvantages compared with primary cell cultures; advantages include the ability to propagate indefinitely, which yields large amounts of protein for study, and cellular homogeneity, which facilitates molecular analysis. 15 The finding that endoglin expression also increased in ischemic mouse brain in vivo helps to validate this approach.
The effects of hypoxia on MAPK activation depend on cell type and conditions. 30 In cultured cortical neurons, hypoxia activated ERK and p38 but decreased activation of JNK. 13, 14 Hypoxia also activates ERK and p38, but not JNK, in PC12 cells 31 and ERK, p38, and JNK in rat pulmonary artery. 32 In this study ERK, p38, and JNK were all phosphoactivated by hypoxia in bEND.3 cells, but studies with kinase inhibitors and constitutively active or dominant negative enzyme constructs implicated only p38 and perhaps JNK1 in induction of endoglin expression. SB202190 and SB203580, which reduced hypoxic induction of endoglin, are potent inhibitors of the p38-␣ and -␤ but not -␥ or -␦ isoforms. 33 ,34 MKK3, constitutive expression of which enhanced hypoxic induction of endoglin, activates p38-␣ and -␥. 34 Therefore, stimulation of endoglin expression by hypoxia is likely conveyed at least partly through MKK3 and p38-␣. How p38 or JNK might regulate hypoxic induction of endoglin is unclear, but p38 is implicated in hypoxic induction of other proteins, including inducible NO synthase 35 and hypoxia-inducible factor-1␣. 36 Figure 6 . Dominant negative MKK3 and constitutively active MKK3 and JNK1 modify endoglin mRNA expression in bEND.3 cells. Cells were transfected for 48 hours with control plasmid or with a plasmid encoding dominant negative [MKK3(Ala)] or constitutively active [MKK3(Glu)] MKK3 or constitutively active JNK1. Cultures were exposed for 16 hours to normoxia or hypoxia, total RNA was extracted and reverse transcribed, and cDNA was used in real-time PCR to measure endoglin expression relative to ␤-actin. Values (meanϮSEM; nϭ3) are expressed relative to normoxia and control vector samples and normalized to ␤-actin (*PϽ0.05 vs control vector).
